Oral administration of the apoA-I mimetic peptide D-4F causes the rapid formation and clearance of small anti-inflammatory HDL-like particles in mice

被引:0
|
作者
Navab, M
Hama, S
Hough, G
Reddy, S
Anantharamaiah, M
Fogelman, A
机构
[1] CHS, Los Angeles, CA USA
[2] UAB, Birmingham, AL USA
[3] Univ Calif Los Angeles, Los Angeles, CA 90024 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1101
引用
收藏
页码:232 / 232
页数:1
相关论文
共 23 条
  • [1] An oral apolipoprotein A-I mimetic peptide, D-4F, converts monkey HDL to anti-inflammatory
    Bachini, EA
    Hama, S
    Yu, N
    Chyu, C
    Hough, G
    FASEB JOURNAL, 2005, 19 (05): : A1055 - A1055
  • [2] D-4F, an ApoA-I mimetic peptide, regulates ABCA1 similar to human ApoA-I
    Grijalva, V
    Martinez, LO
    Altaf, N
    Hama, S
    Reddy, ST
    Navab, M
    Tall, A
    Fogelman, A
    CIRCULATION, 2004, 110 (17) : 37 - 37
  • [3] An apoA-I mimetic peptibody generates HDL-like particles and increases alpha-1 HDL subfraction in mice
    Lu, Shu-Chen
    Atangan, Larissa
    Kim, Ki Won
    Chen, Michelle M.
    Komorowski, Renee
    Chu, Carolyn
    Han, Joon
    Hu, Sylvia
    Gu, Wei
    Veniant, Murielle
    Wang, Minghan
    JOURNAL OF LIPID RESEARCH, 2012, 53 (04) : 643 - 652
  • [4] Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients
    Bloedon, LeAnne T.
    Dunbar, Richard
    Duffy, Danielle
    Pinell-Salles, Paula
    Norris, Robert
    DeGroot, Bruce J.
    Movva, Rajesh
    Navab, Mohamad
    Fogelman, Alan M.
    Rader, Daniel J.
    JOURNAL OF LIPID RESEARCH, 2008, 49 (06) : 1344 - 1352
  • [5] ApoA-I Mimetic Peptide 4F Inhibits Inflammatory Bowel Disease in Mice
    Meriwether, David
    Volpe, Carmen
    Grijalva, Victor
    Mukherjee, Pallavi
    Martin, Martin
    Anantharamaiah, G. M.
    Fogelman, Alan M.
    Reddy, Srinivasa T.
    CIRCULATION, 2016, 134
  • [6] Oral administration of the apolipoprotein A-1 mimetic peptide D-4F in humans with CHD improves HDL anti-inflammatory function after a single dose
    Bloedon, LeAnne T.
    Dunbar, Richard L.
    Duffy, Danielle
    Pinell-Salles, Paula
    Navab, Mohamad
    Fogelman, Alan
    Rader, Daniel J.
    CIRCULATION, 2006, 114 (18) : 288 - 288
  • [7] An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide
    Wool, Geoffrey D.
    Vaisar, Tomas
    Reardon, Catherine A.
    Getz, Godfrey S.
    JOURNAL OF LIPID RESEARCH, 2009, 50 (09) : 1889 - 1900
  • [8] Orally administered statins and an ApoA-1 mimetic peptide (D-4F) act synergistically to render ApoE null mouse HDL anti-inflammatory
    Hama, SH
    FASEB JOURNAL, 2004, 18 (04): : A563 - A563
  • [9] Addition of nanomolar concentrations of D-4F to human plasma in vitro causes the movement of ApoA-I to smaller particles, reduces lipid hydroperoxides, increases paraoxonase activity, and converts proinflammatory HDL to anti-inflammatory
    Yu, N
    Navab, M
    Anantharamaiah, GM
    Chyu, C
    Hama, S
    Hough, GP
    Reddy, ST
    Garber, DW
    Palgunachari, MN
    Fogelman, AM
    CIRCULATION, 2004, 110 (17) : 243 - 243
  • [10] D-4F, an ApoA-I mimetic peptide ameliorating TRPA1-mediated nocifensive behaviour in a model of neurogenic inflammation
    Oehler, Beatrice
    Kloka, Jan
    Mohammadi, Milad
    Ben-Kraiem, Adel
    Rittner, Heike L.
    MOLECULAR PAIN, 2020, 16